278 results Stibbe advises an absence administration company Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products. Stibbe advises confidential client Stibbe advises SCA Hygiene Products Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Purely commercial interest also a legitimate interest? Council of State leaves the question unanswered. On 27 July 2022, the Council of State confirmed that the Dutch Data Protection Authority wrongly imposed a €575,000 fine on VoetbalTV. Zuiver commercieel belang ook gerechtvaardigd belang: Raad van State laat zich er niet over uit Op 27 juli 2022 heeft de Raad van State bevestigd dat de Autoriteit Persoonsgegevens onterecht een boete van € 575.000 aan VoetbalTV heeft opgelegd. The European AI Continent Action Plan On April 9, 2025, the European Commission (EC) presented its new AI Continent Action Plan (the ‘Plan’), setting out a strategic agenda to accelerate the adoption and development of AI throughout the EU. Cyril Fischer Senior Associate Brussels First AI law firm in The Netherlands? Garfield AI just became England’s first approved AI law firm. The purely AI-based firm is a specialised debt-recovery ‘litigation assistant’ that guides users through every step of a small-claims action. Could the Netherlands follow? Stibbe advises Goldman Sachs Stibbe advises Goldman Sachs on the acquisition of Continental Bakeries by Goldman Sachs and The Silverfern Group of NPM Capital, a subsidiary of SHV. Continental Bakeries is a leading European bakery group which produces typical Dutch cookies. To what extent does the WAMCA procedure allow for collective actions for damages due to breaches of the GDPR? Whether it is possible to claim collective damages for an alleged breach of the GDPR by means of WAMCA proceedings has been a recent question within the mass damages practice. What information on this topic can be found in legislation, case law and litera Pagination Previous page Page 13 Page 14 Current page 15 Page 16 Next page
Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.
Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
Purely commercial interest also a legitimate interest? Council of State leaves the question unanswered. On 27 July 2022, the Council of State confirmed that the Dutch Data Protection Authority wrongly imposed a €575,000 fine on VoetbalTV.
Zuiver commercieel belang ook gerechtvaardigd belang: Raad van State laat zich er niet over uit Op 27 juli 2022 heeft de Raad van State bevestigd dat de Autoriteit Persoonsgegevens onterecht een boete van € 575.000 aan VoetbalTV heeft opgelegd.
The European AI Continent Action Plan On April 9, 2025, the European Commission (EC) presented its new AI Continent Action Plan (the ‘Plan’), setting out a strategic agenda to accelerate the adoption and development of AI throughout the EU.
First AI law firm in The Netherlands? Garfield AI just became England’s first approved AI law firm. The purely AI-based firm is a specialised debt-recovery ‘litigation assistant’ that guides users through every step of a small-claims action. Could the Netherlands follow?
Stibbe advises Goldman Sachs Stibbe advises Goldman Sachs on the acquisition of Continental Bakeries by Goldman Sachs and The Silverfern Group of NPM Capital, a subsidiary of SHV. Continental Bakeries is a leading European bakery group which produces typical Dutch cookies.
To what extent does the WAMCA procedure allow for collective actions for damages due to breaches of the GDPR? Whether it is possible to claim collective damages for an alleged breach of the GDPR by means of WAMCA proceedings has been a recent question within the mass damages practice. What information on this topic can be found in legislation, case law and litera